MDT Medtronic Plc

Price (delayed)

$93.16

Market cap

$124.96B

P/E Ratio

26.1

Dividend/share

$2.2

EPS

$3.57

Enterprise value

$145.61B

Business Summary

Sector: Healthcare
Industry: Medical Devices
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Highlights

The price to earnings (P/E) is 22% lower than the 5-year quarterly average of 33.4 and 13% lower than the last 4 quarters average of 29.9
MDT's debt is down by 3% since the previous quarter and by 2.1% year-on-year
The net income has contracted by 10% from the previous quarter but it has grown by 3.4% YoY
The EPS has declined by 10% since the previous quarter but it rose by 3.8% year-on-year
Medtronic plc's quick ratio has decreased by 27% from the previous quarter and by 21% YoY
MDT's gross profit is down by 9% since the previous quarter and by 9% year-on-year

Key stats

Shares outstanding
1.34B
Market cap
$124.96B
Enterprise value
$145.61B
EBIT
$5.13B
EBITDA
$7.79B
Price to earnings (P/E)
26.1
Price to book (P/B)
2.46
Price to sales (P/S)
4.32
EV/EBIT
28.38
EV/EBITDA
18.69
Net debt/EBITDA
2.65
EV/Sales
5.04
EBITDA margin
27%
Gross margin
67.4%
Net margin
16.6%
Operating margin
16.6%
Return on assets
5.2%
Return on equity
9.4%
Return on invested capital
11.6%
Return on capital employed
6.4%
Return on sales
17.7%
Debt to equity
0.49
Free cash flow
$6.02B
Free cash flow per share
$4.49
Book value per share
$37.86
Revenue per share
$21.57
TBVPS
$23.71
Current ratio
2.13
Quick ratio
1.5
Working capital
$11.67B
Dividend yield
2.36%
DPS
$2.2
Payout ratio
61.6%

MDT stock price

Financial performance

The operating income has decreased by 25% QoQ and by 24% YoY
The operating margin has declined by 20% since the previous quarter and by 19% year-on-year
The net income has contracted by 10% from the previous quarter but it has grown by 3.4% YoY
MDT's net margin is up by 9% year-on-year but it is down by 2.9% since the previous quarter

Valuation

Price to earnings (P/E)
Current price to earnings (P/E):
26.1
The price to earnings (P/E) is 22% lower than the 5-year quarterly average of 33.4 and 13% lower than the last 4 quarters average of 29.9
The EPS has declined by 10% since the previous quarter but it rose by 3.8% year-on-year
Price to book (P/B)
Current price to book (P/B):
2.46
The stock's price to book (P/B) is 12% less than its last 4 quarters average of 2.8 but 2.5% more than its 5-year quarterly average of 2.4
The company's equity fell by 2.1% QoQ
Price to sales (P/S)
Current price to sales (P/S):
4.32
MDT's P/S is 8% lower than its last 4 quarters average of 4.7 but 5% higher than its 5-year quarterly average of 4.1
Medtronic plc's revenue has decreased by 7% from the previous quarter and by 5% YoY

Efficiency

The company's return on invested capital fell by 28% YoY and by 24% QoQ
The return on sales has declined by 19% since the previous quarter and by 18% year-on-year
Medtronic plc's return on equity has decreased by 11% QoQ
MDT's return on assets is down by 10% since the previous quarter

Dividends

DPS
$2.2
Dividend yield
2.36%
Payout ratio
61.6%

Recent dividends

Financial health

Assets vs liabilities
The total assets is 128% greater than the total liabilities
Medtronic plc's quick ratio has decreased by 27% from the previous quarter and by 21% YoY
The company's current ratio fell by 23% QoQ and by 18% YoY
Debt vs equity
MDT's debt is 51% smaller than its equity
MDT's debt is down by 3% since the previous quarter and by 2.1% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.